
HKSEHealthcareDrug Manufacturers - Specialty & Generic
Latest quote
HK$8.51
−HK$0.08 · -0.93%
Chia Tai Enterprises International Limited primarily produces and distributes chlortetracycline (CTC) and related goods. Its extensive international reach covers Mainland China, the Asia Pacific region, the Americas, and Europe. The company's operations are divided into two distinct divisions: Biochemical and Industrial. The Biochemical division focuses on the manufacturing and supply of CTC premix and CTC hydrochloride products. These are employed as feed supplements to encourage livestock growth, prevent or cure animal illnesses, and improve feed conversion, sold under the brands Shihao and Citifac. Conversely, the Industrial segment handles the sales, rental, and maintenance of heavy construction machinery, encompassing items such as excavators, power generators, bulldozers, compactors, and their spare parts. This division also fabricates and markets carburetors and other automotive components for various automobile and motorcycle manufacturers. Founded in 1987, the company maintains its headquarters in Central, Hong Kong, and functions as a subsidiary of Charoen Pokphand Foods Public Company Limited.
Latest quote
HK$8.51
−HK$0.08 · -0.93%
Regular session · HKT · Market data may be delayed.
Chia Tai Enterprises International Limited primarily produces and distributes chlortetracycline (CTC) and related goods. Its extensive international reach covers Mainland China, the Asia Pacific region, the Americas, and Europe. The company's operations are divided into two distinct divisions: Biochemical and Industrial. The Biochemical division focuses on the manufacturing and supply of CTC premix and CTC hydrochloride products. These are employed as feed supplements to encourage livestock growth, prevent or cure animal illnesses, and improve feed conversion, sold under the brands Shihao and Citifac. Conversely, the Industrial segment handles the sales, rental, and maintenance of heavy construction machinery, encompassing items such as excavators, power generators, bulldozers, compactors, and their spare parts. This division also fabricates and markets carburetors and other automotive components for various automobile and motorcycle manufacturers. Founded in 1987, the company maintains its headquarters in Central, Hong Kong, and functions as a subsidiary of Charoen Pokphand Foods Public Company Limited.
52-week range
Current HK$8.51
Regular session · HKT · Market data may be delayed.
Chia Tai Enterprises International Limited primarily produces and distributes chlortetracycline (CTC) and related goods. Its extensive international reach covers Mainland China, the Asia Pacific region, the Americas, and Europe. The company's operations are divided into two distinct divisions: Biochemical and Industrial. The Biochemical division focuses on the manufacturing and supply of CTC premix and CTC hydrochloride products. These are employed as feed supplements to encourage livestock growth, prevent or cure animal illnesses, and improve feed conversion, sold under the brands Shihao and Citifac. Conversely, the Industrial segment handles the sales, rental, and maintenance of heavy construction machinery, encompassing items such as excavators, power generators, bulldozers, compactors, and their spare parts. This division also fabricates and markets carburetors and other automotive components for various automobile and motorcycle manufacturers. Founded in 1987, the company maintains its headquarters in Central, Hong Kong, and functions as a subsidiary of Charoen Pokphand Foods Public Company Limited.
52-week range
Current HK$8.51
Profitability as a percentage of reported revenue.
Revenue
Operating income
Net income
| Metric (USD) | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 536.71M USD | 307.75M USD | 173.98M USD | 159.24M USD | 142.41M USD |
| Cost of goods sold | 459.16M USD | 258.81M USD | 140.21M USD | 120.05M USD | 107.65M USD |
| Gross profit | 77.55M USD | 48.93M USD | 30.19M USD | 39.19M USD | 34.76M USD |
| Selling, general, and administrative | 38.6M USD | 37.76M USD | 38.3M USD | 34.31M USD | 29.79M USD |
| Operating expenses | 38.6M USD | 37.76M USD | 34.72M USD | 34.31M USD | 29.79M USD |
| Interest income | 926.37K USD | 1.39M USD | 1.15M USD | 368K USD | 76K USD |
| Interest expense | 1.7M USD | 2.22M USD | 1.95M USD | 994K USD | 648K USD |
| Depreciation and amortization | 9.33M USD | 6.34M USD | 6.39M USD | 6.93M USD | 7.41M USD |
| Operating income | 38.95M USD | 11.18M USD | −4.54M USD | 4.88M USD | 4.97M USD |
| Net income | 32.1M USD | 11.17M USD | 2.55M USD | −6.68M USD | 19.56M USD |
Company facts updated Sep 10, 2026.
Recent quarterly results
Recent quarterly results
Funds reporting this stock among their holdings, ordered by reported position size.
Avantis International Small Cap Value ETFAVDV20.83K—20.51B USD0.36%$111.89-0.42%
Dimensional - International Core Equity 2 ETFDFIC15.88K0.00%15.54B USD0.22%$38.94-0.84%
Avantis International Equity ETFAVDE14.25K—19.18B USD0.23%$92.97-0.77%
Dimensional - International Small Cap ETFDFIS12.6K0.00%5.94B USD0.39%$37.24-0.77%
Avantis International Small Cap Equity ETFAVDS7.13K—352.84M USD0.30%$79.84-0.59%
Dimensional World ex U.S. Core Equity 2 ETFDFAX3.29K0.00%12.76B USD0.28%$38.21-0.66%
Avantis International Small Cap Value ETFAVDV
Dimensional - International Core Equity 2 ETFDFIC
Avantis International Equity ETFAVDE
Dimensional - International Small Cap ETFDFIS
Avantis International Small Cap Equity ETFAVDS
Dimensional World ex U.S. Core Equity 2 ETFDFAXAI-generated and delayed market data for informational and educational purposes only. Not investment advice.